Neuberger Berman Group
PRAX icon

Neuberger Berman Group’s Praxis Precision Medicines PRAX Stock Holding History

Neuberger Berman Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30M Buy
89,468
+63,508
+245% +$20.1M 0.02% 618
2026
Q1 		$8.36M Buy
25,960
+282
+1% +$87.2K 0.01% 861
2025
Q4 		$7.57M Buy
+25,678
New +$4.78M 0.01% 870
2023
Q4 		– Sell
-1,071
Closed -$27.5K – 1906
2023
Q3 		$27.5K Hold
1,071
– – ﹤0.01% 1773
2023
Q2 		$18.5K Buy
+1,071
New +$16.4K ﹤0.01% 1781

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Neuberger Berman Group's PRAX Position: Q2 2026 in Review

Neuberger Berman Group increased its Praxis Precision Medicines (PRAX) stake by 245% in Q2 2026, buying an estimated $20.1M and bringing the position to 89,468 shares worth $30M. The position accounts for 0.02% of the portfolio, ranked #618.

Neuberger Berman Group first reported a position in PRAX in Q2 2023 and has held it in 5 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Neuberger Berman Group held 89,468 shares of Praxis Precision Medicines worth $30M as of Q2 2026.
  • Neuberger Berman Group bought 63,508 Praxis Precision Medicines shares in Q2 2026, an estimated $20.1M.
  • Praxis Precision Medicines made up 0.02% of Neuberger Berman Group's portfolio in Q2 2026, its #618 holding.
  • Neuberger Berman Group first reported a position in Praxis Precision Medicines in Q2 2023 and has held it in 5 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.